Do Analysts Expect Titan Medical Inc. (TMDI) Stock to Rise After It Has Fallen -22.67% in a Month?

Friday, November 12, 2021 11:12 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Titan Medical Inc. (TMDI) Stock to Rise After It Has Fallen -22.67% in a Month?

Wall Street is positive on Titan Medical Inc. (TMDI). On average, analysts give Titan Medical Inc. a Strong Buy rating. The average price target is $4, which means analysts expect the stock to gain by 244.83% over the next twelve months. That average ranking earns Titan Medical Inc. an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating TMDI a Strong Buy today. Find out what this means to you and get the rest of the rankings on TMDI!

See Full TMDI Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Titan Medical Inc. Stock Today?

Titan Medical Inc. (TMDI) stock is trading at $1.16 as of 11:11 AM on Friday, Nov 12, a loss of -$0.09, or -7.19% from the previous closing price of $1.25. The stock has traded between $1.14 and $1.24 so far today. Volume today is elevated. So far 847,352 shares have traded compared to average volume of 563,646 shares. Click Here to get the full Stock Report for Titan Medical Inc. stock.